In the case of HER2 knockdown, reduced proliferation and apoptosis induction was observed in vitro on breast cancer tumors that overexpressed HER2; also, tumor regression after HER2 silencing with shRNA has been observed using in vivo a mouse xenograft model[147,160]. Here, ERBB2 is linked to breast carcinoma.